{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:06:18Z","timestamp":1790201178115,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.sapharm.2025.01.010","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T01:41:37Z","timestamp":1737596497000},"page":"268-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of a drug-related problem oriented medical record in the medication review of critically ill patients \u2013 Randomized clinical trial"],"prefix":"10.1016","volume":"21","author":[{"given":"T\u00e2mara Natasha","family":"Gonzaga de Andrade Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Givalda","family":"Mendon\u00e7a da Cruz Macieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaella","family":"de Oliveira Santos Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"de Carvalho Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Joany","family":"Felizardo Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica Tha\u00eds","family":"Ferreira Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"de Castro Ara\u00fajo Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Rezende","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6985-7836","authenticated-orcid":false,"given":"Divaldo Pereira de","family":"Lyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3192-8285","authenticated-orcid":false,"given":"Alfredo Dias","family":"de Oliveira Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.sapharm.2025.01.010_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7812\/TPP\/09-068","article-title":"Interview with lawrence weed, MD- the father of the problem-oriented medical record looks ahead","volume":"13","author":"Jacobs","year":"2009","journal-title":"Perm J"},{"issue":"6","key":"10.1016\/j.sapharm.2025.01.010_bib2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/amiajnl-2014-002776","article-title":"Bringing science to medicine: an interview with Larry Weed, inventor of the problem-oriented medical record","volume":"21","author":"Wright","year":"2014","journal-title":"J Am Med Inf Assoc"},{"issue":"5","key":"10.1016\/j.sapharm.2025.01.010_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jama.1974.03230430041025","article-title":"The problem-oriented medical record. Experiences in a community military hospital","volume":"229","author":"Aranda","year":"1974","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.sapharm.2025.01.010_bib4","first-page":"100","article-title":"The problem-oriented medical record (POMR)","volume":"10","author":"Rakel","year":"1974","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12913-022-07688-x","article-title":"Healthcare providers' readiness for electronic health record adoption: a cross-sectional study during pre-implementation phase","volume":"22","author":"Ngusie","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"10.1016\/j.sapharm.2025.01.010_bib6","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/18-221","article-title":"A daily hospital progress note that increases physician usability of the electronic health record by facilitating a problem-oriented approach to the patient and reducing physician clerical burden","volume":"23","author":"Sutton","year":"2019","journal-title":"Perm J"},{"issue":"4","key":"10.1016\/j.sapharm.2025.01.010_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijmedinf.2014.12.001","article-title":"Medical documentation: part of the solution, or part of the problem? A narrative review of the literature on the time spent on and value of medical documentation","volume":"84","author":"Clynch","year":"2015","journal-title":"Int J Med Inf"},{"issue":"2","key":"10.1016\/j.sapharm.2025.01.010_bib8","first-page":"155","article-title":"Integration of pharmacy into the computerized problem-oriented medical information system (PROMIS)--a demonstration project","volume":"34","author":"Gilroy","year":"1977","journal-title":"Am J Hosp Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2025.01.010_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.farma.2009.09.007","article-title":"Revision sistem\u00e1tica sobre la implantaci\u00f3n y la evaluaci\u00f3n del seguimiento farmacoterap\u00e9utico en pacientes hospitalizados","volume":"34","author":"Silva-Castro","year":"2010","journal-title":"Farm Hosp"},{"issue":"3","key":"10.1016\/j.sapharm.2025.01.010_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/jrpp.JRPP_18_17","article-title":"Validating a drug-related problems classification system in outpatient setting in Iran","volume":"7","author":"Roshanzamiri","year":"2018","journal-title":"J Res Pharm Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2025.01.010_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.CCM.0000300275.63811.B3","article-title":"Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay","volume":"36","author":"Marshall","year":"2008","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.sapharm.2025.01.010_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/0897190012467209","article-title":"Pharmacist-developed sedation protocol and impact on ventilator days","volume":"26","author":"Hahn","year":"2013","journal-title":"J Pharm Pract"},{"issue":"10","key":"10.1016\/j.sapharm.2025.01.010_bib13","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1007\/s001340101065","article-title":"Medication administration errors in adult patients in the ICU","volume":"27","author":"Calabrese","year":"2001","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.sapharm.2025.01.010_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/jcpt.12250","article-title":"More than just crushing: a prospective pre-post intervention study to reduce drug preparation errors in patients with feeding tubes","volume":"40","author":"Lohmann","year":"2015","journal-title":"J Clin Pharm Therapeut"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/2193-1801-3-34","article-title":"Development of clinical pharmacy services for intensive care units in Korea","volume":"3","author":"Kim","year":"2014","journal-title":"SpringerPlus"},{"issue":"2","key":"10.1016\/j.sapharm.2025.01.010_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7196\/SAJCC.194","article-title":"The need for pharmaceutical care in an intensive care unit at a teaching hospital in South Africa","volume":"30","author":"Bronkhorst","year":"2014","journal-title":"South African J Crit Care"},{"issue":"12","key":"10.1016\/j.sapharm.2025.01.010_bib17","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1097\/CCM.0b013e31818f2269","article-title":"Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections","volume":"36","author":"MacLaren","year":"2008","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.sapharm.2025.01.010_bib18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s11096-018-0696-7","article-title":"PCNE definition of medication review: reaching agreement","volume":"40","author":"Griese-Mammen","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1062860613482964","article-title":"Comparison of intensive care unit medication errors reported to the United States' MedMarx and the United Kingdom's National Reporting and Learning System: a cross-sectional study","volume":"29","author":"Wahr","year":"2014","journal-title":"Am J Med Qual"},{"issue":"2","key":"10.1016\/j.sapharm.2025.01.010_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/0972-5229.175931","article-title":"Impact of clinical pharmacist in an Indian intensive care unit","volume":"20","author":"Sivakumar","year":"2016","journal-title":"Indian J Crit Care Med"},{"issue":"3","key":"10.1016\/j.sapharm.2025.01.010_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s11096-020-01150-w","article-title":"Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation","volume":"43","author":"Schindler","year":"2021","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2025.01.010_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjms.2021.03.007","article-title":"The impact of an established pharmaceutical care pathway on drug related problems in an intensive care unit","volume":"362","author":"Toukhy","year":"2021","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.sapharm.2025.01.010_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0976-3147.83574","article-title":"Utilization patterns of central nervous system drugs: a cross-sectional study among the critically ill patients","volume":"2","author":"John","year":"2011","journal-title":"J Neurosci Rural Pract"},{"issue":"5","key":"10.1016\/j.sapharm.2025.01.010_bib24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2753.2006.00753.x","article-title":"An innovative approach to integrated medicines management","volume":"13","author":"Scullin","year":"2007","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.sapharm.2025.01.010_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.preghy.2021.11.005","article-title":"Influence of drug-related problems on length of hospital stay of women with a history of preeclampsia: a multicenter study","volume":"27","author":"Goes","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.sapharm.2025.01.010_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.154578","article-title":"Drug-related problems in the intensive care units","volume":"81","author":"Polat","year":"2024","journal-title":"J Crit Care"},{"key":"10.1016\/j.sapharm.2025.01.010_bib27","doi-asserted-by":"crossref","unstructured":"\u00c7ak\u0131r A, Memi\u015f H, G\u00fcn Z\u00fc, B\u0131\u00e7akc\u0131o\u011flu M. Evaluation of drug-related problems of intensive care unit patients by clinical pharmacists: a retrospective longitudinal study. Turkish J Pharm Sci. Published online December 25, 2023:0-0. doi:10.4274\/tjps.galenos.2023.44459.","DOI":"10.4274\/tjps.galenos.2023.44459"},{"key":"10.1016\/j.sapharm.2025.01.010_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/20503121221090881","article-title":"Drug-related problems identified during pharmaceutical care interventions in an intensive care unit at a tertiary university hospital","volume":"10","author":"Tharanon","year":"2022","journal-title":"SAGE Open Med"},{"issue":"2","key":"10.1016\/j.sapharm.2025.01.010_bib29","first-page":"1","article-title":"Pattern of drug therapy related problems encountered by clinical pharmacists in a critical care setting in Nepal","volume":"21","author":"Acharya","year":"2023","journal-title":"Pharm Pract"},{"issue":"5","key":"10.1016\/j.sapharm.2025.01.010_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jac5.1779","article-title":"Characterization of <scp>drug\u2010related<\/scp> problems and evaluation of pharmacist interventions in the cardiovascular intensive care settings in Thailand","volume":"6","author":"Wattanaruengchai","year":"2023","journal-title":"JACCP J Am Coll Clin Pharm"},{"key":"10.1016\/j.sapharm.2025.01.010_bib31","article-title":"Clinical pharmacist interventions in an intensive care unit reduces ICU mortality at a tertiary hospital in Dubai, United Arab Emirates","volume":"14","author":"Ali","year":"2024","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"12","key":"10.1016\/j.sapharm.2025.01.010_bib32","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/MEG.0000000000001492","article-title":"Identifying characteristics of drug-related problems in critically ill patients with decompensated liver cirrhosis","volume":"31","author":"Aghili","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.sapharm.2025.01.010_bib33","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/CCM.0000000000003830","article-title":"Impact on patient outcomes of pharmacist participation in multidisciplinary critical care teams: a systematic review and meta-analysis","volume":"47","author":"Lee","year":"2019","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.sapharm.2025.01.010_bib34","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/01.CCM.0000171609.91035.BD","article-title":"The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care","volume":"33","author":"Rothschild","year":"2005","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.sapharm.2025.01.010_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00228-021-03214-w","article-title":"Drug-related deaths among inpatients: a meta-analysis","volume":"78","author":"Patel","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib36","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1080\/07853890.2022.2105390","article-title":"Does professionalism change with different sociodemographic variables? A survey of Arab medical residents","volume":"54","author":"Alfaris","year":"2022","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.sapharm.2025.01.010_bib38","author":"G"},{"key":"10.1016\/j.sapharm.2025.01.010_bib39","series-title":"IMPACTO DE UM MODELO DE PRONTU\u00c1RIO ORIENTADO PARA PROBLEMAS RELACIONADOS A MEDICAMENTOS SOBRE INDICADORES HOSPITALARES DE PACIENTES CR\u00cdTICOS","author":"Santos","year":"2020"},{"issue":"7","key":"10.1016\/j.sapharm.2025.01.010_bib40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.sapharm.2025.01.010_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"Apache II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib42","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","article-title":"The SOFA score\u2014development, utility and challenges of accurate assessment in clinical trials","volume":"23","author":"Lambden","year":"2019","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13054-017-1609-1","article-title":"SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis","volume":"21","author":"de Grooth","year":"2017","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.sapharm.2025.01.010_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/cc7160","article-title":"Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review","volume":"12","author":"Minne","year":"2008","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.sapharm.2025.01.010_bib45","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.sapharm.2019.07.006","article-title":"Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients","volume":"16","author":"Leache","year":"2020","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13054-019-2665-5","article-title":"The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort","volume":"23","author":"Karakike","year":"2019","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41598-023-50881-z","article-title":"Reduced length of intensive care unit stay and early mechanical ventilator weaning with enhanced recovery after surgery (ERAS) in free fibula flap surgery","volume":"14","author":"Hsiao","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010151","article-title":"Hemodynamic predictors for sepsis-induced acute kidney injury: a preliminary study","volume":"9","author":"Antal","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.sapharm.2025.01.010_bib49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.medin.2019.11.007","article-title":"Risk factors associated to noninvasive ventilation failure in primary influenza A pneumonia in the critical care setting","volume":"45","author":"Hern\u00e1ndez Garc\u00e9s","year":"2021","journal-title":"Med Intensiva"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib50","first-page":"244","article-title":"Sequential organ failure assessment score on admission predicts long-term mortality in acute heart failure patients","volume":"7","author":"Aoyama","year":"2020","journal-title":"ESC Hear Fail."},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12913-022-07494-5","article-title":"Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital","volume":"22","author":"Albayrak","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"10.1016\/j.sapharm.2025.01.010_bib52","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/1060028018759343","article-title":"Critical care pharmacists and medication management in an ICU recovery center","volume":"52","author":"Stollings","year":"2018","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.sapharm.2025.01.010_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2146\/ajhp150186","article-title":"Pharmacist involvement in a multidisciplinary initiative to reduce sepsis-related mortality","volume":"73","author":"Beardsley","year":"2016","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2025.01.010_bib54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41598-020-80560-2","article-title":"Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions","volume":"11","author":"Garin","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.sapharm.2025.01.010_bib55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11096-014-0063-2","article-title":"Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention","volume":"37","author":"Silva","year":"2015","journal-title":"Int J Clin Pharm"},{"issue":"7","key":"10.1016\/j.sapharm.2025.01.010_bib56","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00228-014-1686-x","article-title":"Application of drug-related problem (DRP) classification systems: a review of the literature","volume":"70","author":"Basger","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.sapharm.2025.01.010_bib57","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1345\/aph.1D182","article-title":"Drug-related problem classification systems","volume":"38","author":"van Mil","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.1016\/j.sapharm.2025.01.010_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235353","article-title":"Prevalence of clinically manifested drug interactions in hospitalized patients: a systematic review and meta-analysis","volume":"15","author":"Gonzaga de Andrade Santos","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.sapharm.2025.01.010_bib59","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1067\/mem.2001.119456","article-title":"Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department","volume":"38","author":"Hohl","year":"2001","journal-title":"Ann Emerg Med"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:18:42Z","timestamp":1745396322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741125000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1551741125000105"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.01.010","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of a drug-related problem oriented medical record in the medication review of critically ill patients \u2013 Randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}